Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC W24 AI therapy platform at $2M revenue 2024 with 8K+ users at $20/month; $3.4M from YC/Moonfire/Reddit/Instacart founders; full speech/text CBT-informed sessions 24/7 competing with Woebot and BetterHelp for AI mental health.
Sonia is a San Francisco-based AI mental health platform — backed by Y Combinator (W24) with $3.4 million in total funding including a seed round from Y Combinator, Moonfire Ventures, and angel investors from Reddit and Instacart — providing consumers with an AI therapist that conducts full speech and text-based therapy sessions through a phone app at $20 per month or $200 annually, addressing depression, anxiety, relationship challenges, and sleep disorders through 24/7 on-demand AI therapy conversations using evidence-based approaches. Founded in 2023 by Chris Aeberli, Dustin Klebe, and Lukas Wolf (MIT AI research background), Sonia achieved $2 million in revenue in 2024 with 13 employees and 8,000+ users.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.